| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,728 |
4,333 |
$1.19M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
27,869 |
25,696 |
$1.02M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,392 |
15,039 |
$987K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
28,786 |
25,606 |
$218K |
| 80053 |
Comprehensive metabolic panel |
20,738 |
18,796 |
$201K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,156 |
4,739 |
$198K |
| 62322 |
|
1,117 |
652 |
$96K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,175 |
2,824 |
$95K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,826 |
1,688 |
$95K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,495 |
5,909 |
$66K |
| 83735 |
|
6,885 |
6,193 |
$43K |
| 87400 |
|
4,742 |
2,213 |
$27K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,082 |
1,013 |
$25K |
| 83690 |
|
4,480 |
4,115 |
$25K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
604 |
519 |
$25K |
| 80306 |
|
2,574 |
2,280 |
$25K |
| 62323 |
|
161 |
158 |
$23K |
| 82553 |
|
2,025 |
1,782 |
$21K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
348 |
321 |
$19K |
| 84484 |
|
2,457 |
2,127 |
$18K |
| 81003 |
|
7,061 |
6,522 |
$16K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,569 |
1,438 |
$14K |
| 81001 |
|
4,179 |
3,790 |
$14K |
| 71046 |
Radiologic examination, chest; 2 views |
1,545 |
1,395 |
$12K |
| 82550 |
|
2,141 |
1,883 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,504 |
1,347 |
$11K |
| 0001A |
|
321 |
302 |
$11K |
| 81025 |
|
3,252 |
2,916 |
$10K |
| 70450 |
Computed tomography, head or brain; without contrast material |
190 |
169 |
$10K |
| 86738 |
|
497 |
467 |
$9K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
48 |
46 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
1,822 |
1,658 |
$8K |
| 83880 |
|
375 |
339 |
$8K |
| 0002A |
|
227 |
221 |
$8K |
| 87077 |
|
789 |
733 |
$7K |
| 87430 |
|
346 |
324 |
$5K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
32 |
12 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
224 |
203 |
$4K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
98 |
53 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
13 |
12 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
188 |
169 |
$923.80 |
| 80076 |
|
146 |
144 |
$920.32 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
970 |
902 |
$885.24 |
| 87449 |
|
27 |
27 |
$550.42 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,277 |
1,145 |
$362.52 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
177 |
165 |
$362.17 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
76 |
72 |
$359.52 |
| 87071 |
|
59 |
56 |
$319.77 |
| 72110 |
|
31 |
29 |
$159.18 |
| 73560 |
|
31 |
14 |
$102.42 |
| 73030 |
|
28 |
12 |
$83.64 |
| 82962 |
|
26 |
24 |
$64.43 |
| 72050 |
|
15 |
13 |
$56.58 |
| 73521 |
|
15 |
13 |
$51.78 |
| 82248 |
|
13 |
13 |
$36.05 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
41 |
36 |
$29.45 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
374 |
345 |
$10.15 |
| J2704 |
Injection, propofol, 10 mg |
261 |
248 |
$8.40 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
51 |
49 |
$0.41 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
806 |
663 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
767 |
624 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
116 |
98 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
44 |
38 |
$0.00 |
| 91300 |
|
552 |
451 |
$0.00 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
13 |
13 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
14 |
13 |
$0.00 |